SeekIn Inc, o le taʻitaʻi o le kanesa faʻavae toto vave suʻesuʻeina ma mataʻituina tekinolosi, i aso nei na faʻasalalau le CE (Conformité Européenne) Mark mo SeekInCare® Cancer Detection Kit ma ua sauni nei e faʻalauiloa lenei suʻega i maketi a Europa.
Toeitiiti atoa le 10 miliona tagata na maliliu i le kanesa i le tausaga talu ai i le lalolagi atoa. Ole tele ole kanesa ua tuai tele ona togafitia. Ole su'esu'ega vave ole kanesa fa'amaonia ile falema'i e mafai ona fa'asaoina ola, ae na'o le aofia ai o nai ituaiga o kanesa e pei ole mama, colon, ate, susu, manava ma le prostate e fa'atapula'a le su'esu'eina ma fa'apitoa. O se su'ega e tasi e su'esu'e lelei ai kanesa uma ua manatu o le sini autu mo le su'esu'eina o le kanesa mo tagata uma.
O le SeekIn e iai se fa'avae fa'avae fa'apitoa e fa'aoga ai fa'amatalaga mai fa'amatalaga tumaoti ma fa'amatalaga fa'alaua'itele e iloa ai le vaivai ole kanesa ole DNA ma fa'ailoga polotini i totonu ole toto ma toe su'e i tua ile aano o le afuaga. SeekIn ei ai pateni i algorithms e faʻaitiitia ai le pisa i tua ma faʻaalia faailo o le kanesa i le toto.
"O se laasaga tele lea i la matou misiona e aumaia le kanesa faʻavae toto vave suʻesuʻeina i le puleaina o le kanesa masani," o le tala lea a Mao Mao, MD, Ph.D., le faʻavae ma le Pule Sili o SeekIn, i se faʻamatalaga. "O le kanesa o se vaega o loʻu aiga ma ua ou tuuto atu aʻu lava e atiaʻe le faʻaogaina o le toto-faʻavaeina o tekonolosi vave e iloa ai le kanesa talu mai le 2014. Na musuia e la matou suʻesuʻega faʻapitoa i le 2 miliona fafine, matou te faia se auala tulaga ese e puʻeina ai le genomic masani ma vaega epigenetic o le kanesa i totonu o le toto, lea e fai ma sui o se tasi o tekinolosi tetele e tolu e siaki ai le tele o ituaiga kanesa e faʻaaoga ai se paipa toto. O le tu'ufa'atasia ma fa'ailoga polotini masani, o le a mafai ai e lenei su'ega ona iloa le tele o ituaiga o kanesa i tagata mama'i e leai ni fa'aaliga pe a sili atu ona mafai ona fofo le kanesa. O le fa'ailogaina o le CE o se fa'ailoga taua tele mo Su'esu'e i le aumaia o su'ega a Su'esu'ega i tagata mama'i ma tausi soifua maloloina i Europa. O le a faʻaauau a matou taumafaiga e faʻamalieina manaʻoga faʻaopoopo i Europa, ma ia maua faʻamaoniga faʻatonutonu i isi teritori e pei o Saina ma Iapani.
OA MEA E AVEA MAI LENEI TUSI:
- Inspired by our clinical study in 2 million women, we took a unique approach to capture the common genomic and epigenetic features of cancer in blood, which represents one of the three major technologies to screen multiple cancer types using a tube of blood.
- SeekIn has an artificial intelligence-based platform that uses insights from both private and public data to identify weak cancer DNA and protein signals in the blood and trace them back to a tissue of origin.
- SeekIn Inc, o le taʻitaʻi o le kanesa faʻavae toto vave suʻesuʻeina ma mataʻituina tekinolosi, i aso nei na faʻasalalau le CE (Conformité Européenne) Mark mo SeekInCare® Cancer Detection Kit ma ua sauni nei e faʻalauiloa lenei suʻega i maketi a Europa.
